Oncopeptides (Sweden) Technical Analysis
| ONCO Stock | SEK 1.54 0.03 1.99% |
As of the 23rd of November, Oncopeptides holds the Coefficient Of Variation of (812.67), variance of 14.15, and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncopeptides, as well as the relationship between them.
Oncopeptides Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Oncopeptides, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OncopeptidesOncopeptides |
Oncopeptides technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Oncopeptides AB Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Oncopeptides AB volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Oncopeptides AB Trend Analysis
Use this graph to draw trend lines for Oncopeptides AB. You can use it to identify possible trend reversals for Oncopeptides as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Oncopeptides price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Oncopeptides Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Oncopeptides AB applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Oncopeptides AB market price will keep on failing further. It has 122 observation points and a regression sum of squares at 4.28, which is the sum of squared deviations for the predicted Oncopeptides price change compared to its average price change.About Oncopeptides Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Oncopeptides AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Oncopeptides AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Oncopeptides AB price pattern first instead of the macroeconomic environment surrounding Oncopeptides AB. By analyzing Oncopeptides's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Oncopeptides's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Oncopeptides specific price patterns or momentum indicators. Please read more on our technical analysis page.
Oncopeptides November 23, 2024 Technical Indicators
Most technical analysis of Oncopeptides help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oncopeptides from various momentum indicators to cycle indicators. When you analyze Oncopeptides charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.13) | |||
| Mean Deviation | 2.07 | |||
| Coefficient Of Variation | (812.67) | |||
| Standard Deviation | 3.76 | |||
| Variance | 14.15 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (1.14) | |||
| Maximum Drawdown | 34.67 | |||
| Value At Risk | (3.69) | |||
| Potential Upside | 3.83 | |||
| Skewness | (2.86) | |||
| Kurtosis | 20.97 |
Additional Tools for Oncopeptides Stock Analysis
When running Oncopeptides' price analysis, check to measure Oncopeptides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncopeptides is operating at the current time. Most of Oncopeptides' value examination focuses on studying past and present price action to predict the probability of Oncopeptides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncopeptides' price. Additionally, you may evaluate how the addition of Oncopeptides to your portfolios can decrease your overall portfolio volatility.